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Abstract
The gastrointestinal (GI) track represents an important battlefield where pathogens first try to gain
entry into a host. It is also a universe where highly diverse and ever changing inhabitants co-exist
in an exceptional equilibrium without parallel in any other organ system of the body. The gut as an
organ has its own well-developed and fully functional immune organization that is similar and yet
different in many important ways to the rest of the immune system. Both a compromised and an
overactive immune system in the gut can have dire and severe consequences to human health. It
has therefore been of great interest to develop animal models that recapitulate key aspects of the
human condition to better understand the interplay of the host immune system with its friends and
its foes. However, reconstitution of the GI tract in humanized mice has been difficult and highly
variable in different systems. A better molecular understanding of the development of the gut
immune system in mice has provided critical cues that have been recently used to develop novel
humanized mouse models that fully recapitulate the genesis and key functions of the gut immune
system of humans. Of particular interest is the presence of human gut-associated lymphoid tissue
(GALT) aggregates in the gut of NOD/SCID BLT humanized mice that demonstrate the faithful
development of bona fide human plasma cells capable of migrating to the lamina propria and
producing human IgA1 and IgA2.
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The GI: a critical immune organ
The immune system’s function is to respond to pathogens. In the gut however, the immune
system has to respond to pathogens while remaining somewhat unresponsive to the
commensal flora and a large range of food antigens (Macdonald and Monteleone, 2005).
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Abnormalities in gut immune function have been implicated in the development of
ulcerative colitis and Crohn’s disease (Chandran et al., 2003). One specific instance in
which the need for a better understanding human GALT genesis and regeneration has been
made extremely clear is illustrated during the course of HIV infection. Even at the earliest
stages of infection, the virus inflicts extraordinary damage to the gut immune system that is
incomparable to the changes observed in the rest of the body and certainly not reflected in
peripheral blood (Dandekar, 2007; Mehandru and Dandekar, 2008). This damage is
widespread and long lasting. Even extensive antiretroviral therapy cannot appreciably
restore the harm done (Guadalupe et al., 2003).
Human gut development
Due to the intrinsic difficulties in performing studies in humans, little is known about human
GALT development. However, this is not the case in other species. Recent studies have
generated a great deal of relevant and significant insight into the molecular and cellular
mechanisms by which GALT genesis occurs in mice (Mebius, 2003; Kiyono and Fukuyama,
2004; van de Pavert and Mebius, 2010). Though a series of elegant genetic experiments,
cryptopatches have been identified as the key site for the organogenesis of isolated lymphoid
tissue in the gut (Kanamori et al., 1996; Saito et al., 1998; Oida et al., 2000; Suzuki et al.,
2000; Eberl and Littman, 2004; Eberl, 2005; Pabst et al., 2005; Bouskra et al., 2008). To
date, the presence of these anlagen for immune aggregates in humans has not been fully
established. Despite these advances in our knowledge of mouse GALT development, our
understanding of human GALT genesis is sparse. The difficulties associated with
performing similar developmental studies in humans has limited our current knowledge of
human GALT to anatomical and pathological descriptions (Cornes, 1965). In humans,
lymphocyte migration into mucosal tissues like the gut is the result of a series of poorly
understood but highly complex interactions involving cell adhesion molecules and
chemokines with their corresponding receptors (Kunkel and Butcher, 2002). In a recent
series of studies, our laboratory focused on the evaluation of gut reconstitution in several
different humanized mouse models. The results demonstrated a seminal role for
cryptopatches in human GALT genesis.
Humanized mouse models
Early in the 1980’s, pioneering work from the laboratory of John E. Dick and others
established the repopulation of immunodeficient mice with human hematopoietic cells
(Kamel-Reid and Dick, 1988; Dick, 1991; Dick et al., 1991; Vormoor et al., 1994; Hogan et
al., 1997; Wang et al., 1998). Since then many variants of “humanized mice” have been
described and these models have been reviewed extensively elsewhere (Denton and Garcia,
2009; Brehm et al., 2010; Denton and Garcia, 2011; Shultz et al., 2012). It was only after
much iteration, that finally one humanized mouse model was developed with remarkable
reconstitution of the GI: the bone marrow/liver/thymus or BLT humanized mouse (Melkus
et al., 2006; Sun et al., 2007).
Virtually all modern humanized mouse models are produced via transplantation of human
hematopoietic cells into one of several different strains of immune deficient mice. This
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results in systemic reconstitution with human hematopoietic cells including B cells,
monocytes/macrophages and T cells. In most models, the human T cells are produced in the
mouse thymus and are presumed to be educated in the context of mouse MHC I and II
(Traggiai et al., 2004; Ishikawa et al., 2005; Shultz et al., 2005). In the case of BLT mice,
human liver and thymus tissue are implanted under the kidney capsule to develop a
functional human thymus in which T cells can develop in the presence of human thymic
epithelium resulting in HLA I and II restriction (Wege et al., 2008; Olesen et al., 2011). The
second step is a bone marrow transplant from which T cell progenitors and other human
hematopoietic cells are derived resulting in systemic reconstitution with all types of human
hematopoietic cells (Lan et al., 2006; Melkus et al., 2006).
Early descriptions of gut reconstitution in humanized mice
The first clear demonstration of the presence of human cells in the gut of humanized mice
was made by Melkus et al (Melkus et al., 2006). In this manuscript, the presence of human
cells in the GI of BLT mice was determined with immunohistochemistry. Human T cells, B
cells and myeloid cells present in the GI tract of these mice were described as forming
aggregates resembling gut-associated lymphoid tissue (Melkus et al., 2006). Subsequently,
Sun et al. (Sun et al., 2007) performed a detail flow cytometric characterization of the
different types of human T cells present in the GI tract of BLT mice. In this report, the
investigators show the presence of human T and B cells, monocyte/macrophages and
dendritic cells in all sections of the gut. In addition, they demonstrated substantial numbers
of lamina propria (LP) and intraepithelial (IE) CD4+, CD8+ and CD4+CD8+ T cells in the
small and large intestines (Sun et al., 2007). The presence of double positive T cells is
characteristic of this human tissue (Carton et al., 2004) and is an indicator of its faithful
reconstitution in BLT mice. Also of note is the fact that the human intestinal T cells present
in BLT mice display a memory phenotype as is observed in the human gut (Sun et al.,
2007). Another indication that the reconstitution of the gut in BLT mice is indeed reflective
of the human gut is the presence of CD8 single positive T cells in the lamina propria that
expressed both the CD8α and CD8β chains which is in contrast with the exclusive
expression of the CD8α chain in the double positive T cells also found in the lamina propria
(Sun et al., 2007). All of these observations are fully consistent with what has been
described for human gut (Abuzakouk et al., 1998; Carton et al., 2004).
Concurrent with the demonstration of the presence of human cells in the gut of BLT mice,
Akkina and colleagues in an elegant study also demonstrated the presence of human
lymphoid cells in the gut of humanized DKO mice using immunohistochemistry (Berges et
al., 2008). The presence of human cells in the GI tract of these mice was subsequently
confirmed by Hofer et al (Hofer et al., 2008). Similarly, the presence of human T cells in the
gut of humanized NSG mice has also been described (Holt et al., 2010).
A recent study by Denton et al. investigated the differences and similarities in gut
reconstitution between all of these humanized mouse models (Denton et al., 2012). This
study presents a detailed head-to-head comparison between humanized DKO, NSG, NOD/
SCID BLT and NSG BLT mice. Since each of these strains of mice differs in the number of
CD34+ cells needed for optimal engraftment, the investigators adjusted the number of cells
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used for transplantation to obtain optimal systemic reconstitution of each model. The authors
noted that regardless of the mouse strain or the humanization protocol (i.e. transplantation
alone or transplantation of thy/liv implanted animals) all mice were reconstituted as
evidenced by the presence of human T cells in peripheral blood (Denton et al., 2012).
Analysis of the systemic reconstitution of each of these mouse models demonstrated the
presence of human T cells in bone marrow, spleen, liver and lung. Extensive comparisons
within and between models were conducted of which only a few showed differences
between groups. The notable differences indicated somewhat lower levels of human cells in
the tissues of humanized DKO mice. These results were evidence of the systemic
reconstitution of each of these mouse models allowing as indicated below for a direct
comparison of their gut reconstitution with T cells.
A tale of two thymi
In CD34+ cell transplant only mice made using DKO or NSG animals, all of the human T
cells present are produced in the endogenous mouse thymus (Traggiai et al., 2004; Ishikawa
et al., 2005; Shultz et al., 2005). In CD34+ cell transplanted NOD/SCID mice there are no
human T cells (Palucka et al., 2003; Islas-Ohlmayer et al., 2004; Cravens et al., 2005).
Therefore, in NOD/SCID BLT mice the only cells present are derived from the human
thymic implant (Melkus et al., 2006). However, in NSG BLT mice, human T cells are
produced in both the endogenous mouse thymus and the exogenous implanted human
thymus (Denton et al., 2012). Regardless of the way in which mice are humanized or the
strain used, in all cases, a diverse T cell receptor repertoire is generated indicating efficient
T cell genesis and development (Traggiai et al., 2004; Melkus et al., 2006; Marodon et al.,
2009). In NSG BLT mice, the vast majority of thymocytes originate from the implanted
human tissue. The numbers of total thymocytes in NOD/SCID and NSG BLT mice are
similar. However, the numbers of thymocytes in CD34+ cell transplanted only NSG or DKO
mice were found to be significantly lower when compared to NSG and NOD/SCID BLT
mice (Denton et al., 2012).
Reconstitution of the GI tract with human T cells in different humanized
mouse models
Having established systemic reconstitution with human T cells in each of the different
humanized mouse models, an analysis for the presence of T cells in the GI tract was
performed (Denton et al., 2012). Both the large and small intestines were analyzed.
Interestingly, whereas both of the BLT mouse models and the NSG CD34+ cell transplanted
mice had significant levels of human T cells in all parts of the gut, these cells were present
in lower levels in the tissues obtained from DKO CD34+ cell transplanted mice. In virtually
all cases, this difference was statistically significant. Analysis for the presence of lamina
propria and intraepithelial lymphocytes demonstrated the presence of these cells in both
BLT models and CD34+ transplant only NSG mice, albeit in appreciably different amounts.
However, these cells were virtually absent from DKO CD34+ cell transplanted mice
(Denton et al., 2012). In all cases, BLT mice had the highest and most consistent levels of
human T cells throughout all portions of the intestines. Both NOD/SCID and NSG BLT
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mice had similar levels of human T cells in the small intestine lamina propria. This was not
the case in other portions of the intestines. Specifically, NOD/SCID BLT mice had more
human intraepithelial lymphocytes in both the large and small intestine and in the large
intestine lamina propria than NSG-BLT mice. NOD/SCID BLT mice had more human T
cells in all portions of the intestine than CD34+ NSG transplanted mice. However, in the
large intestine, CD34+ cell transplanted only NSG mice had more human intraepithelial and
lamina propria lymphocytes than NSG-BLT mice.
Qualitative differences between the human T cells present in humanized
mice made using the NSG or NOD/SCID mouse strains
The quantitative differences in the repopulation of the different parts of the gut between
different models prompted the evaluation of other possible qualitative differences. Diversity
in T cell receptor (TCR) expression is essential for a well functioning immune system.
Analysis of the TCR repertoire in the T cells present in BLT mice generated in NOD/SCID
and NSG strains has been recently reported (Denton et al., 2012). Small intestine
intraepithelial and lamina propria lymphocytes were isolated from multiple mice and pooled
for immunoscope analysis of TCR diversity. The results demonstrated that the TCR
repertoire in the gut of these mice was quite diverse and included all of the 28 variable beta
regions tested. Interestingly, the authors indicate that the diversity observed was reminiscent
to that observed in young humans (Probert et al., 2007; Denton et al., 2012). One interesting
observation reported was the fact that whereas the double positive T cells found in the small
intestine of NOD/SCID BLT mice expressed the CD8αα homodimer, the T cells found in
the small intestine of NSG BLT mice did not. This remarkable difference was taken as an
indication that perhaps the mouse gamma chain molecule that is present in NOD/SCID BLT
mice and but completely absent in the NSG BLT mice might contribute to the bona fide
reconstitution of the NOD/SCID BLT mouse gut.
The role of the gamma chain molecule and cryptopatches in the
development of GALT in humanized mice
The role of cryptopatches in the development of GALT in mice has been extensively
documented (van de Pavert and Mebius, 2010). However, these important structures have
been the subject of significant debate since they were originally considered to be absent in
humans (Moghaddami et al., 1998; Pabst et al., 2005). The interest in the presence of these
structures in humans has been fuelled by a recent report revealing the presence of structures
resembling crytopatches in human gastrointestinal tissue (Lugering et al., 2010). This issue
was recently addressed in great detail in a manuscript by Nochi et al (Nochi et al., 2013). In
this report, the authors analyzed the presence of cryptopatches in two different strains of
immunodeficient mice commonly used to generate humanized mice NOD/SCID and NSG.
The critical difference between these two strains of mice that permitted this analysis was the
presence or absence of the common gamma chain receptor molecule in NOD/SCID and
NSG mice, respectively.
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The GALT consists of two major components: Peyer’s patches and isolated lymphoid
follicles. It is in these two distinct structures where antigen-primed T and B cells can be
activated endowing them with the ability to migrate into the lamina propria where they can
execute their functions. Peyer’s patches are generated during gestation and their number
increases until puberty (Cornes, 1965). In contrast, isolated lymphoid follicles develop after
birth in response to commensal bacteria present in the gut (van de Pavert and Mebius, 2010).
It is for these reasons that humanized mice can potentially develop lymphoid follicles but
not Peyer’s patches. The formation of isolated lymphoid follicles is elegantly orchestrated
by a series of well-defined events that are dependent on the presence of lymphoid tissue
inducer cells. Key to the development of isolated lymphoid follicles is the production of
IL-7 by epithelial cells. IL-7 is necessary for the induction of lymphotoxin. Lymphotoxin in
turn is responsible for the production of cytokines, chemokines and adhesion molecules by
lymphoid tissue organizer cells. These molecules are essential for the recruitment and
retention of lymphocytes (Eberl, 2005; Eberl, 2007). Therefore, IL-7R signaling is essential
for GALT development.
IL-7R signaling is mediated by the common gamma chain of the IL-2 receptor gene. The
common gamma chain is a cytokine receptor subunit that is shared by the IL-2, -4, -7, -9,
-15 and -21 receptors (Wang et al., 2005). In the absence of this molecule, cells are unable to
respond to the signaling initiated by the binding of these cytokines. Consistent with the lack
of IL-7R signaling, cryptopatches only developed within the intestinal crypts of NOD/SCID
mice and were not found anywhere within the gut of NSG mice (Nochi et al., 2013).
Whereas in NOD/SCID mice these structures failed to fully develop due to the absence of
mouse T and B cells, they did become enlarged with a follicle-associated epithelium.
Using flow cytometric analysis, at least two kinds of murine innate immune cells
(IL-7Rapha+c-kit+) were identified in the intestines of NOD/SCID mice. One cell type
expressed mouse CD4 which defined them as lymphoid tissue inducer cells. The second cell
type expressed mouse NKp46 defining them as natural cytotoxicity-triggering receptor cells.
It should be noted that these cells were absent in the gut of NSG mice. These results in total
demonstrated the presence of cryptopatches in NOD/SCID mice that could serve as the basis
for the development of GALT in these animals.
Development of GALT-like structures in NOD/SCID BLT mice
Examination of the GI tract of NOD/SCID BLT mice revealed the presence of immune
aggregates in both the small and large intestine. Early after stem cell transplantation with
human CD34+ cells, these aggregates contain mainly mouse CD45+ cells and a few human
CD45+ cells (Nochi et al., 2013). Over time, these aggregates expand due to the
accumulation of human T cells, B cells, monocyte/macrophages and dendritic cells. On the
basis of the presence of all these different types of immune cells in these aggregates, they
were defined as GALT-like structures (Jung et al., 2010). It is important to highlight that
these structures were completely absent in all of the NSG mice examined in this report,
providing a striking correlation between the presence of a common gamma chain and the
presence of GALT in BLT humanized mice (Nochi et al., 2013). However, despite the
absence of GALT structures in NSG BLT mice, their GI tract is well reconstituted with T
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cells, monocyte/macrophages and dendritic cells. Nevertheless, human B cells are almost
completely absent in the gut of NSG BLT mice.
Human CD19+ B cells were mostly absent from the lamina propria of NOD/SCID BLT
mice. B cells in NOD/SCID mice were almost exclusively found in the GALT and expressed
activation-induced cytidine deaminase (Delker et al., 2009). Unswitched human IgM+ B
cells together with class-switched human IgA+ and IgG+ cells were found in GALT
structures of NOD/SCID BLT mice, reflective of heterogeneous populations of B cells in the
process of differentiation into plasma cells. However, co-expression of human IgA with
other markers like CD27, CD38 and CD138 together with a lack of HLA-DR expression
confirmed the presence of fully differentiated plasma cells. Consistent with the sequential
maturation and subsequent migration of plasma cells, significantly higher numbers of human
IgA+ cells than IgG or IgM cells were found in the lamina propria of NOD/SCID BLT mice.
These cells were rarely found in NSG BLT mice suggesting that the existence of human
plasma cells in the intestinal lamina propria of BLT mice is dependent on the presence of
GALT structures. Of note, like in humans, both human IgA1 and IgA2 expressing cells were
found in the gut of NOD/SCID BLT mice.
The humanized BLT mouse as a model to study the role of the gut in HIV
pathogenesis, transmission and prevention
The gut is a tissue of great importance during the course of HIV disease. The gut houses the
majority of the body’s HIV target cells (Mowat and Viney, 1997). In developed nations,
HIV is commonly acquired through the gut. Long after the initial infection HIV persists in
the gut from where it can be transmitted to others (Shacklett and Anton, 2010). There are
numerous clinical manifestations of gut involvement during HIV infection including
diarrhea, dehydration and enteropathy. HIV infection also inflicts significant long-lasting
damage to the immune system that is manifested by a systemic loss of peripheral and tissue
CD4+ T cells. Damage to the immune system is mostly repaired after administration of
antiretroviral therapy (ART) (Connick et al., 2000; Hirsch et al., 2004). Unfortunately, this
most significant benefit of ART does not extend to the gut (Mehandru et al., 2006;
Dandekar, 2007).
Because of the multiple roles that the gut plays in HIV disease there has been strong interest
in the development and implementation of animal models that can recapitulate key aspects
of HIV infection and pathogenesis in the gut. In this regard, humanized BLT mice have
often served as outstanding models of HIV infection in the gut. Because of the extensive
reconstitution of the gut of BLT mice they have also been extensively used to study rectal
HIV transmission, its pathogenic sequela and its possible prevention (Sun et al., 2007;
Chateau et al., 2013; Nochi et al., 2013). Humanized BLT mice were the first model ever
used to study rectal HIV transmission. In a landmark paper, Sun et al. demonstrated that
BLT mice could be infected after a single rectal exposure to HIV (Sun et al., 2007). The
authors also demonstrated that infection resulted in significant destruction of the human T
cells present throughout the entire gut of these animals. More recently, BLT mice were used
to investigate the use of topical microbicides to prevent rectal HIV transmission (Chateau et
al., 2013). In this study, humanized BLT mice were used to determine whether or not a
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single topical application of Tenofovir could prevent rectal HIV acquisition in BLT mice.
The results from this study demonstrated that rectally applied Tenofovir is highly effective
at preventing rectal HIV transmission and further validated the model for the study of HIV
transmission and prevention approaches. More recently, Nochi et al demonstrated that the
GALT structures themselves in BLT mice are targets for destruction by HIV as well as sites
of extensive replication. All of these studies have taken advantage of the unique
characteristics that set apart the BLT model for studies of the gut during health and disease.
Summary
The GALT is an essential component of a fully functional human immune system. Detail
analyses of the GI tract of several commonly used humanized mouse models have been
conducted. Whereas most models contain human lymphoid cells in their gut, only NOD/
SCID BLT mice contain aggregates resembling bona fide GALT structures and have human
IgA-1 and -2 expressing plasma cells in their intestines. The presence of these well-defined
immune structures is dependent on the presence of cryptopatches. The presence of
cryptopatches in turn is dependent on the expression of the common gamma chain of the
IL-2 receptor. These observations have significant implications for the field of humanized
mice since the vast majority of models currently in use take advantage of the higher levels of
humanization that can be obtained in strains of mice lacking this gene such as NSG, NOG
and DKO mice. Consequently, none of the humanized mice developed in these mouse
strains develops human GALT structures or has human IgA producing plasma cells in their
lamina propria. Therefore, currently, the NOD/SCID BLT humanized mouse model is the
only available platform for the study of the development and function of human GALT
during health and disease conditions.
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• Gut associated lymphoid tissue is an important component of the immune
system.
• Cryptopatches are essential for the development of GALT.
• Only certain strains of immunodeficient mice contain cryptopatches.
• Only strains of mice that have cryptopatches can develop human GALT.
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